Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Cutia Therapeutics announced positive top-line results from its Phase II clinical trial of CU-20401 for treating submental adipose accumulation.
Cutia Therapeutics has completed a Phase II clinical trial in China for CU-20401, a novel drug targeting submental adipose accumulation.